#7 - Medtronic (NYSE:MDT)
Medtronic (MDT) Medtronic (NYSE:MDT) operates at the intersection of two growing sectors: health care and technology. One area that the company is involved in is medical devices. This is a long-standing favorite of bullish investors and right now seems no different. Prior to the market correction MDT stock was up over 25% in the past 12 months compared to the industry average of 10%.
The company had a mixed earnings report that found them missing on revenue. And the company advised that 2020 earnings and revenue may be impacted by the coronavirus. But shares were largely unaffected. This may be because of Medtronic’s long-term investment in digital surgery. This brings together health care with artificial intelligence (AI). It’s an area that shows a high growth potential as only 2% of current surgeries worldwide are performed with the help of robotic systems.
MDT stock has a dividend yield of 2.21% and pays out an annual dividend of $2.16 per share. The company has posted annual dividend growth of 6.07% over the last three years and has 42 years of consecutive dividend growth.
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Read More - Current Price
- $86.21
- Consensus Rating
- Hold
- Ratings Breakdown
- 7 Buy Ratings, 9 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $95.00 (10.2% Upside)
